Sort
261,768 grants matching “gene therapy”
The Integrative Genomics of Acute Asthma Control
$846,161Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2015 · HL
CHRONIC INTESTINAL INFLAMMATION--MECHANISMS AND EFFECTS
$846,105University Of Alabama At Birmingham · P01 · FY2003 · DK
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation
$845,988Gay Miriam Crooks · University Of California Los Angeles · R01 · FY2023 · AI
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
$845,852Joseph Patti · Agilvax, Inc. · R44 · FY2019 · CA
The IL-18-IFNγ axis predicts response to immunotherapy
$845,823Heather Leigh Herd Gustafson · Seattle Children'S Hospital · R37 · FY2023 · CA
Insights into immune-related disease born from population genomics
$845,812Peter R Parham · Stanford University · U01 · FY2017 · AI
The Functional Consequences of the 17q12 Asthma Susceptibility Locus
$845,795Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2016 · HL
High-Throughput Molecular Profiling Core
$845,786Michael G Katze · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
CAMPO Clinical Trials Program
$845,784Joel Palefsky · University Of California, San Francisco · U54 · FY2020 · CA
Integrative genomic, epigenetic and functional studies in diabetic kidney disease
$845,751Joel N Hirschhorn · Broad Institute, Inc. · R01 · FY2016 · DK
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
$845,738Galit Alter · Massachusetts General Hospital · R01 · FY2012 · AI
Characterization of Persistent COVID-19
$845,667Jonathan Li · Brigham And Women'S Hospital · R01 · FY2025 · AI
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease
$845,621Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · EB
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
$845,606Alain Charest · Tufts Medical Center · R01 · FY2014 · CA
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
$845,606Anne M Connolly · Research Inst Nationwide Children'S Hosp · U01 · FY2024 · NS
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$845,601Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2023 · CA
Pathogenesis of Neurological Disability in Primary Diseases of Myelin
$845,598Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2024 · NS
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$845,528Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Glucoregulatory Hormone Interactions in Diabetes
$845,452Douglas Lyle Rothman · Yale University · R01 · FY2021 · DK
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$845,443Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · R01 · FY2025 · AI
Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism
$845,394Ashley Hall Shoemaker · Vanderbilt University Medical Center · R01 · FY2024 · DK
Isolation, characterization, and transplantation of candidate stem cells
$845,339John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Systems Biology Identifies Restriction Factors for West Nile Virus
$845,316Michael S. Diamond · University Of Wisconsin-Madison · U19 · FY2016 · AI
WU-SN-TMC Bio-Analysis Core
$845,309Feng Chen · Washington University · U54 · FY2025 · AG
A new genetic approach for studying prions and other pathogenic protein aggregate
$845,250Ann Hochschild · Harvard Medical School · DP1 · FY2008 · OD